For example, inhibition of IDO expression in tumour cells by imatinib activates CD8+ T cells in the tumour and induces T(reg) cell apoptosis, which, in combination with immunotherapy, significantly enhances the therapeutic effect of imatinib in mice (88). This evidence concerns the gene CD8A and neoplasm.